Oncology
What we do
This is a specialized department that provides high-level medical care by utilizing advanced knowledge of all malignant tumors. The treatment plan is decided and implemented according to the type and stage of cancer and the patient's condition. In cooperation with the departments involved (surgical and internal medicine), for example, when surgery is optimal plan, treatment is performed by a surgeon, when radiation is optimal, radiation therapy is performed by the radiology department, and when treatment with medication such as anticancer agents is optimal, we are developing a multidisciplinary treatment. If hospitalization is required, we work together with Kameda General Hospital in Kamogawa. Our department is a specialized department that always understands the entire medical treatment of patients' cancers and deals with them. We will also provide and explain the latest treatments available in Japan and around the world.
Both first-time patients and those who have already been treated at other hospitals are welcome. We also accept a second opinion. We will do our best for recurrence and difficult diseases.
Please feel free to come and visit us. Dr. Oyama who is a director of the department can also provide medical treatment explanations in English.
Japan Clinical Oncology Society Certified Training Facility
Japan Cancer Treatment Certified Medical Facility Certification Training Facility
Director of the Oncology Department
Dr. Yu Oyama, M.D.
Both first-time patients and those who have already been treated at other hospitals are welcome. We also accept a second opinion. We will do our best for recurrence and difficult diseases.
Please feel free to come and visit us. Dr. Oyama who is a director of the department can also provide medical treatment explanations in English.
Japan Clinical Oncology Society Certified Training Facility
Japan Cancer Treatment Certified Medical Facility Certification Training Facility
Director of the Oncology Department
Dr. Yu Oyama, M.D.
Conditions we handle
Heart tumor
・ Systemic sarcoma: leiomyosarcoma, MFH, liposarcoma, angiosarcoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, etc.
・Respiratory: lung cancer, thymoma and cancer, sarcoma, pleural mesothelioma
・Gastrointestinal: esophageal cancer, gastric cancer, small intestine cancer, colon cancer,pancreatic cancer, gallbladder cancer, endocrine tumor, liver cancer
・ Breast: Breast cancer, primary malignant tumor of the breast
・ Head and neck: pharyngeal cancer, tongue cancer, laryngeal cancer, etc.
・ Urology: renal cancer, bladder cancer, testicular cancer, prostate cancer
・ Brain tumor: Glioblastoma, oligodendrocyte tumor, astrocytoma, metastatic brain tumor
・ Gynecologic cancer: ovarian cancer, uterine cancer, primary peritoneal cancer, sarcoma
・ Others: skin cancer, melanoma, cancer of unknown primary origin, neuroendocrine tumor
・ Systemic sarcoma: leiomyosarcoma, MFH, liposarcoma, angiosarcoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, etc.
・Respiratory: lung cancer, thymoma and cancer, sarcoma, pleural mesothelioma
・Gastrointestinal: esophageal cancer, gastric cancer, small intestine cancer, colon cancer,pancreatic cancer, gallbladder cancer, endocrine tumor, liver cancer
・ Breast: Breast cancer, primary malignant tumor of the breast
・ Head and neck: pharyngeal cancer, tongue cancer, laryngeal cancer, etc.
・ Urology: renal cancer, bladder cancer, testicular cancer, prostate cancer
・ Brain tumor: Glioblastoma, oligodendrocyte tumor, astrocytoma, metastatic brain tumor
・ Gynecologic cancer: ovarian cancer, uterine cancer, primary peritoneal cancer, sarcoma
・ Others: skin cancer, melanoma, cancer of unknown primary origin, neuroendocrine tumor
Number of cases
(2011)
Average number of outpatients: 60/day
Average number of hosptialized inpatients: 70/all time
Average number of a cases: 800/year
Average number of outpatients: 60/day
Average number of hosptialized inpatients: 70/all time
Average number of a cases: 800/year
Operation results
none
List of Doctors
-
Chief of OncologyYu OYAMASubspeciality
Hematology, Oncology, Bone Marrow Transplantation, Autoimmune associated diseases.
Chief of Oncology
Yu OYAMA
Subspeciality
Hematology, Oncology, Bone Marrow Transplantation, Autoimmune associated diseases.Department name Oncology Medical School Nihon University School of Medicine Special Qualifications Board Certified Physician of Japanease Society of Internal Medicine
Baord Certified Specialist of American Internal Medicine
Board Certified Specialist of American Oncology
Board Certified Specialist of American Hematology
Board Advanced Certified Specialist of Japanese Society of Medical Oncology
Baord Tentative instructor of Japan Board of Cancer TherapyEducation & Career 1991.Mar. Graduated from Nihon University School of Medicine
1991.Apr. Residency in Internal Medicine, St,Luke’s International Hospital
1994.May. Clinical Fellow in Hematology/Pulmonary and Critical Care Medicine,Nihon University Hospitals
1996.Jun. Residency in Internal Medicine, Thomas Jefferson University Hospital
1999.Jul. Clinical Fellow in Hematology/Oncology/Stem Cell Transplantation, Northwestern University Medical School
2002.Jul. Clinical Director,Division of Immunotherapy, Assistant Professor,Department of Medicine, Northwestern University Attending Physician,Department of Medicine,Northwestern Memorial Hospital
2006.Oct. Chief ofl Oncology, Kameda Medical Center
- Orthopedics
- Sports Medicine Center
- Gastroenterological Surgery
- Plastic Surgery
- Neurosurgery
- Neuroendovascular Surgery
- Spine Surgery
- General Thoracic Surgery
- Cardiovascular
- Breast Center
- Obstetrics
- Gynecology
- Assisted Reproductive Technology Center
- Urology
- Urogynecology Center
- Dermatology
- Ophthalmology
- Head and Neck Surgery
- Otorhinolaryngology (ENT)
- Renal Transplant Center
- Lymphedema Surgery
- Surgical Oncology
